PRESS RELEASES

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and

Read More

Ambiq Announces Pricing of Upsized Initial Public Offering

Ambiq Announces Pricing of Initial Public Offering Ambiq Announces Pricing of Initial Public Offering AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of

Read More

Meltwater Debuts Industry-First GenAI Lens, Unlocking Enhanced Brand Insights

SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs (Large Language

Read More

Mavenir Completes Comprehensive Recapitalization

Transaction eliminates more than $1.3 billion of existing debt and secures $300 million of new senior financing, meaningfully strengthening Mavenir’s balance sheet. Mavenir well-positioned for sustained growth and long-term success. Siris remains controlling shareholder with support from key existing Mavenir lenders. RICHARDSON, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Mavenir, the

Read More